{"id":"https://openalex.org/W2471089142","doi":"https://doi.org/10.1158/1535-7163.mct-15-0924","title":"BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members","display_name":"BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members","alternate_titles":[],"publication_year":2016,"publication_date":"2016-09-01","ids":{"openalex":"https://openalex.org/W2471089142","doi":"https://doi.org/10.1158/1535-7163.mct-15-0924","mag":"2471089142","pmid":"https://pubmed.ncbi.nlm.nih.gov/27406984"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-15-0924","doi":"https://doi.org/10.1158/1535-7163.mct-15-0924","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-15-0924","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2471089142"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048140105","display_name":"Simon J. Hogg","orcid":"https://orcid.org/0000-0002-3170-839X","observed_orcids":["https://orcid.org/0000-0002-3170-839X"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Simon J. Hogg","raw_affiliation_strings":["1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2800555584"]},{"raw_affiliation_string":"2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044968757","display_name":"Andrea Newbold","orcid":"https://orcid.org/0000-0002-0481-2431","observed_orcids":["https://orcid.org/0000-0002-0481-2431"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrea Newbold","raw_affiliation_strings":["1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070073059","display_name":"Stephin J. Vervoort","orcid":"https://orcid.org/0000-0001-7459-126X","observed_orcids":["https://orcid.org/0000-0001-7459-126X"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephin J. Vervoort","raw_affiliation_strings":["1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060004543","display_name":"Leonie A. Cluse","orcid":"https://orcid.org/0000-0001-8613-0508","observed_orcids":["https://orcid.org/0000-0001-8613-0508"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leonie A. Cluse","raw_affiliation_strings":["1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044148458","display_name":"Benjamin P. Martin","orcid":"https://orcid.org/0009-0000-8986-1509","observed_orcids":["https://orcid.org/0009-0000-8986-1509"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Benjamin P. Martin","raw_affiliation_strings":["1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057423528","display_name":"Gareth Peter Gregory","orcid":"https://orcid.org/0000-0002-4170-0682","observed_orcids":["https://orcid.org/0000-0002-4170-0682"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]},{"id":"https://openalex.org/I4210121067","display_name":"Monash Health","ror":"https://ror.org/02t1bej08","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121067"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gareth P. Gregory","raw_affiliation_strings":["1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia","3Monash Hematology, Monash Health, Clayton, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2800555584"]},{"raw_affiliation_string":"2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]},{"raw_affiliation_string":"3Monash Hematology, Monash Health, Clayton, Victoria, Australia","institution_ids":["https://openalex.org/I4210121067"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083360286","display_name":"Marcus Lefebure","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marcus Lefebure","raw_affiliation_strings":["1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2800555584"]},{"raw_affiliation_string":"2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002479431","display_name":"Eva Vidacs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eva Vidacs","raw_affiliation_strings":["1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082677312","display_name":"Richard W. Tothill","orcid":"https://orcid.org/0000-0003-4522-1184","observed_orcids":["https://orcid.org/0000-0003-4522-1184"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard W. Tothill","raw_affiliation_strings":["1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110274677","display_name":"James E. Bradner","orcid":"https://orcid.org/0000-0002-2718-4415","observed_orcids":["https://orcid.org/0000-0002-2718-4415","https://orcid.org/0000-0003-1422-5318"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James E. Bradner","raw_affiliation_strings":["4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057674362","display_name":"Jake Shortt","orcid":"https://orcid.org/0000-0003-3185-6488","observed_orcids":["https://orcid.org/0000-0003-3185-6488"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]},{"id":"https://openalex.org/I4210121067","display_name":"Monash Health","ror":"https://ror.org/02t1bej08","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121067"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jake Shortt","raw_affiliation_strings":["1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia","3Monash Hematology, Monash Health, Clayton, Victoria, Australia","5School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2800555584"]},{"raw_affiliation_string":"2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]},{"raw_affiliation_string":"3Monash Hematology, Monash Health, Clayton, Victoria, Australia","institution_ids":["https://openalex.org/I4210121067"]},{"raw_affiliation_string":"5School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia","institution_ids":["https://openalex.org/I4210121067","https://openalex.org/I56590836"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052829828","display_name":"Ricky W. Johnstone","orcid":"https://orcid.org/0000-0001-7053-9237","observed_orcids":["https://orcid.org/0000-0001-7053-9237"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ricky W. Johnstone","raw_affiliation_strings":["1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gene Regulation Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2800555584"]},{"raw_affiliation_string":"2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5057674362"],"corresponding_institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584","https://openalex.org/I4210121067","https://openalex.org/I56590836"],"apc_list":null,"apc_paid":null,"fwci":3.1711,"has_fulltext":false,"cited_by_count":82,"citation_normalized_percentile":{"value":0.9323192,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"15","issue":"9","first_page":"2030","last_page":"2041"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bet-inhibitors","display_name":"BET inhibitors","score":0.9179999828338623},{"id":"https://openalex.org/keywords/jq1","display_name":"JQ1","score":0.9909999966621399},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.8619999885559082},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9340000152587891},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.8799999952316284},{"id":"https://openalex.org/keywords/building-information-modeling","display_name":"building information modeling","score":0.9300000071525574},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.8379999995231628},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":0.9900000095367432},{"id":"https://openalex.org/keywords/p53-independent-apoptosis","display_name":"p53-independent apoptosis","score":0.8100000023841858},{"id":"https://openalex.org/keywords/mitochondrial-apoptosis","display_name":"mitochondrial apoptosis","score":0.6480000019073486},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7870000004768372},{"id":"https://openalex.org/keywords/ras-activation","display_name":"Ras activation","score":0.6389999985694885},{"id":"https://openalex.org/keywords/nras","display_name":"NRAS","score":0.9369999766349792},{"id":"https://openalex.org/keywords/epigenetic-regulation","display_name":"epigenetic regulation","score":0.9520000219345093}],"concepts":[{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.9136633276939392},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.6826512217521667},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6721765995025635},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.6368089318275452},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6243728995323181},{"id":"https://openalex.org/C2780862049","wikidata":"https://www.wikidata.org/wiki/Q25326844","display_name":"BET inhibitor","level":5,"score":0.5936375856399536},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.5610125660896301},{"id":"https://openalex.org/C149150037","wikidata":"https://www.wikidata.org/wiki/Q554446","display_name":"Bcl-2 family","level":4,"score":0.5070607662200928},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.4860959053039551},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4726216793060303},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.45054566860198975},{"id":"https://openalex.org/C2776789625","wikidata":"https://www.wikidata.org/wiki/Q4875408","display_name":"Bcl-xL","level":4,"score":0.412895143032074},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3575570285320282},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20555442571640015},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1779663860797882},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14195463061332703},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.0},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005810","descriptor_name":"Multigene Family","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016259","descriptor_name":"Genes, myc","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044127","descriptor_name":"Epigenesis, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-15-0924","doi":"https://doi.org/10.1158/1535-7163.mct-15-0924","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-15-0924","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:27406984","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27406984","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W1523117612","https://openalex.org/W1536014543","https://openalex.org/W1926704304","https://openalex.org/W1951627305","https://openalex.org/W1968075576","https://openalex.org/W1976033223","https://openalex.org/W1977258127","https://openalex.org/W1982494540","https://openalex.org/W1992993494","https://openalex.org/W1993186884","https://openalex.org/W2002395443","https://openalex.org/W2007648282","https://openalex.org/W2009949436","https://openalex.org/W2017789254","https://openalex.org/W2032058375","https://openalex.org/W2041535798","https://openalex.org/W2041746617","https://openalex.org/W2044874589","https://openalex.org/W2056641238","https://openalex.org/W2056936324","https://openalex.org/W2066680949","https://openalex.org/W2068570492","https://openalex.org/W2069019880","https://openalex.org/W2069123340","https://openalex.org/W2072981794","https://openalex.org/W2090714945","https://openalex.org/W2091988355","https://openalex.org/W2092175362","https://openalex.org/W2097870229","https://openalex.org/W2105085478","https://openalex.org/W2120572492","https://openalex.org/W2128605424","https://openalex.org/W2129129812","https://openalex.org/W2133070589","https://openalex.org/W2135589851","https://openalex.org/W2144002645","https://openalex.org/W2159862107","https://openalex.org/W2162520885","https://openalex.org/W2162696088","https://openalex.org/W2205700110","https://openalex.org/W2226721679","https://openalex.org/W2315308806"],"related_works":["https://openalex.org/W2460139889","https://openalex.org/W3044002025","https://openalex.org/W6983483615","https://openalex.org/W2293393098","https://openalex.org/W3015278991","https://openalex.org/W3174570086","https://openalex.org/W2610257765","https://openalex.org/W2128605424","https://openalex.org/W2193786745","https://openalex.org/W4401914444"],"abstract_inverted_index":{"Targeting":[0],"BET":[1,34,55,181],"bromodomain":[2],"proteins":[3],"using":[4],"small":[5],"molecules":[6],"is":[7,59],"an":[8],"emerging":[9],"anticancer":[10],"strategy":[11],"with":[12,57,98,139],"clinical":[13],"evaluation":[14],"of":[15,33,49,63,71,81,141,166,180],"at":[16],"least":[17],"six":[18],"inhibitors":[19,182],"now":[20],"underway.":[21],"Although":[22],"MYC":[23],"downregulation":[24],"was":[25,133,137],"initially":[26],"proposed":[27],"as":[28],"a":[29,60,155],"key":[30],"mechanistic":[31],"property":[32],"inhibitors,":[35],"recent":[36],"evidence":[37],"suggests":[38],"that":[39,54,66,113],"additional":[40],"antitumor":[41],"activities":[42],"are":[43],"important.":[44],"Using":[45],"the":[46,69,79,93,178],"E\u03bc-Myc":[47,144],"model":[48],"B-cell":[50,185],"lymphoma,":[51],"we":[52],"demonstrate":[53],"inhibition":[56],"JQ1":[58,77,156],"potent":[61],"inducer":[62],"p53-independent":[64],"apoptosis":[65,106,167],"occurs":[67],"in":[68,125,129,183],"absence":[70],"effects":[72],"on":[73,164],"Myc":[74],"gene":[75],"expression.":[76],"skews":[78],"expression":[80],"proapoptotic":[82],"(Bim)":[83],"and":[84,136,153,169],"antiapoptotic":[85],"(BCL-2/BCL-xL)":[86],"BCL-2":[87,132,152],"family":[88],"members":[89],"to":[90,118,147,171],"directly":[91],"engage":[92],"mitochondrial":[94],"apoptotic":[95],"pathway.":[96],"Consistent":[97],"this,":[99],"Bim":[100],"knockout":[101],"or":[102,121],"Bcl-2":[103],"overexpression":[104],"inhibited":[105],"induction":[107,168],"by":[108],"JQ1.":[109],"We":[110],"identified":[111],"lymphomas":[112,145],"were":[114],"either":[115],"intrinsically":[116],"resistant":[117],"JQ1-mediated":[119],"death":[120],"acquired":[122,154],"resistance":[123,157,170],"following":[124],"vivo":[126],"exposure.":[127],"Strikingly,":[128],"both":[130],"instances":[131],"strongly":[134],"upregulated":[135,151],"concomitant":[138],"activation":[140],"RAS":[142],"pathways.":[143],"engineered":[146],"express":[148],"activated":[149],"Nras":[150],"phenotype.":[158],"These":[159],"studies":[160],"provide":[161],"important":[162],"information":[163],"mechanisms":[165],"BET-inhibition,":[172],"while":[173],"providing":[174],"further":[175],"rationale":[176],"for":[177],"translation":[179],"aggressive":[184],"lymphomas.":[186],"Mol":[187],"Cancer":[188],"Ther;":[189],"15(9);":[190],"2030-41.":[191],"\u00a92016":[192],"AACR.":[193]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2471089142","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-07-22T00:00:00"}
